FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377564802> ?p ?o ?g. }

• W4377564802 abstract "To investigate the mechanism underlying the effects of berberine (BBR) in the treatment of Alzheimer's disease (AD).3 × Tg AD mice were treated with BBR for 3 months, then the open field test (OFT), the novel object recognition test (NOR) and the Morris water maze (MWM) test were performed to assess behavioral performance. Hematoxylin-eosin (HE) staining, Nissl staining were used to examine histopathological changes. The pharmacological and molecular properties of BBR were obtained from the TCMSP database. BBR-associated AD targets were identified using the PharmMapper (PM), the comparative toxicogenomics database (CTD), DisGeNet and the human gene database (GeneCards). Core networks and BBR targets for the treatment of AD were identified using PPI network and functional enrichment analyses. AutoDock software was used to model the interaction between BBR and potential targets. Finally, RT-qPCR, western blotting were used to validate the expression of core targets.Behavioral experiments, HE staining and Nissl staining have shown that BBR can improve memory task performance and neuronal damage in the hippocampus of AD mice. 117 BBR-associated targets for the treatment of AD were identified, and 43 genes were used for downstream functional enrichment analysis in combination with the results of protein-protein interaction (PPI) network analysis. 2,230 biological processes (BP) terms, 67 cell components (CC) terms, 243 molecular function (MF) terms and 118 KEGG terms were identified. ALB, EGFR, CASP3 and five targets in the PI3K-AKT signaling pathway including AKT1, HSP90AA1, SRC, HRAS, IGF1 were selected by PPI network analysis, validated by molecular docking analysis and RT-q PCR as core targets for further analysis. Akt1 mRNA expression levels were significantly decreased in AD mice and significantly increased after BBR treatment (p < 0.05). Besides, AKT and ERK phosphorylation decreased in the model group, and BBR significantly increased their phosphorylation levels.AKT1, HSP90AA1, SRC, HRAS, IGF1 and ALB, EGFR, CASP3 were core targets of BBR in the treatment of AD. BBR may exert a neuroprotective effect by modulating the ERK and AKT signaling pathways." @default.
• W4377564802 created "2023-05-24" @default.
• W4377564802 creator A5003607548 @default.
• W4377564802 creator A5003799076 @default.
• W4377564802 creator A5016392867 @default.
• W4377564802 creator A5043226608 @default.
• W4377564802 creator A5048458636 @default.
• W4377564802 creator A5071841470 @default.
• W4377564802 creator A5075946545 @default.
• W4377564802 creator A5081634959 @default.
• W4377564802 date "2023-05-04" @default.
• W4377564802 modified "2023-10-17" @default.
• W4377564802 title "Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway" @default.
• W4377564802 cites W119643968 @default.
• W4377564802 cites W1501358501 @default.
• W4377564802 cites W1595969134 @default.
• W4377564802 cites W1612435886 @default.
• W4377564802 cites W1692324497 @default.
• W4377564802 cites W1973930904 @default.
• W4377564802 cites W1977854052 @default.
• W4377564802 cites W1983530802 @default.
• W4377564802 cites W1992477322 @default.
• W4377564802 cites W2002659179 @default.
• W4377564802 cites W2015192576 @default.
• W4377564802 cites W2024431507 @default.
• W4377564802 cites W2026750502 @default.
• W4377564802 cites W2047363417 @default.
• W4377564802 cites W2049894439 @default.
• W4377564802 cites W2054466658 @default.
• W4377564802 cites W2056891806 @default.
• W4377564802 cites W2069528345 @default.
• W4377564802 cites W2070603512 @default.
• W4377564802 cites W2072625879 @default.
• W4377564802 cites W2074513890 @default.
• W4377564802 cites W2076422310 @default.
• W4377564802 cites W2079224783 @default.
• W4377564802 cites W2079334276 @default.
• W4377564802 cites W2101257013 @default.
• W4377564802 cites W2104916446 @default.
• W4377564802 cites W2124679671 @default.
• W4377564802 cites W2124757426 @default.
• W4377564802 cites W2129582474 @default.
• W4377564802 cites W2134204786 @default.
• W4377564802 cites W2134967712 @default.
• W4377564802 cites W2140495119 @default.
• W4377564802 cites W2144086069 @default.
• W4377564802 cites W2146578030 @default.
• W4377564802 cites W2151155970 @default.
• W4377564802 cites W2168351285 @default.
• W4377564802 cites W2537679995 @default.
• W4377564802 cites W2561378381 @default.
• W4377564802 cites W2611425558 @default.
• W4377564802 cites W2625356606 @default.
• W4377564802 cites W2626707658 @default.
• W4377564802 cites W2794144617 @default.
• W4377564802 cites W2796793162 @default.
• W4377564802 cites W2809668203 @default.
• W4377564802 cites W2902301648 @default.
• W4377564802 cites W2921619174 @default.
• W4377564802 cites W2924395156 @default.
• W4377564802 cites W2961295616 @default.
• W4377564802 cites W2961794370 @default.
• W4377564802 cites W2961954273 @default.
• W4377564802 cites W2969324996 @default.
• W4377564802 cites W2971875589 @default.
• W4377564802 cites W2983166786 @default.
• W4377564802 cites W3017921754 @default.
• W4377564802 cites W3046062670 @default.
• W4377564802 cites W3104268602 @default.
• W4377564802 cites W3117019186 @default.
• W4377564802 cites W3154998545 @default.
• W4377564802 cites W3158891634 @default.
• W4377564802 cites W3162538759 @default.
• W4377564802 cites W3162839253 @default.
• W4377564802 cites W3165646674 @default.
• W4377564802 cites W3169255554 @default.
• W4377564802 cites W3182962580 @default.
• W4377564802 cites W3185519974 @default.
• W4377564802 cites W3200530131 @default.
• W4377564802 cites W4200006707 @default.
• W4377564802 cites W4206774749 @default.
• W4377564802 cites W4210722399 @default.
• W4377564802 cites W4224313356 @default.
• W4377564802 cites W4225258118 @default.
• W4377564802 cites W4282841265 @default.
• W4377564802 cites W4283779221 @default.
• W4377564802 cites W4310817535 @default.
• W4377564802 cites W4319345558 @default.
• W4377564802 cites W608457234 @default.
• W4377564802 doi "https://doi.org/10.3389/fnins.2023.1059496" @default.
• W4377564802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37214397" @default.
• W4377564802 hasPublicationYear "2023" @default.
• W4377564802 type Work @default.
• W4377564802 citedByCount "5" @default.
• W4377564802 countsByYear W43775648022023 @default.
• W4377564802 crossrefType "journal-article" @default.
• W4377564802 hasAuthorship W4377564802A5003607548 @default.
• W4377564802 hasAuthorship W4377564802A5003799076 @default.
• W4377564802 hasAuthorship W4377564802A5016392867 @default.
• W4377564802 hasAuthorship W4377564802A5043226608 @default.

• next